---
document_datetime: 2023-09-21 22:23:34
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/rydapt-epar-all-authorised-presentations_en.pdf
document_name: rydapt-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.7210111
conversion_datetime: 2025-12-23 03:49:00.78437
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| MA (EU) number   | (Invented) name   | Strength   | Pharmaceutical form   | Route of administration   | Immediate packaging      | Pack size    |
|------------------|-------------------|------------|-----------------------|---------------------------|--------------------------|--------------|
| EU/1/17/1218/001 | Rydapt            | 25 mg      | Capsule, soft         | Oral use                  | blister (PA/alu/PVC/alu) | 112 capsules |
| EU/1/17/1218/002 | Rydapt            | 25 mg      | Capsule, soft         | Oral use                  | blister (PA/alu/PVC/alu) | 56 capsules  |